LONDON, March 17 (Reuters) - There is a lot of reassuring
evidence that suggests there is no increased risk of blood clots
from AstraZeneca's COVID-19 vaccine, England's deputy chief
medical officer said, adding he expected the European Medicines
Agency to agree.
"Behind the scenes, there is a lot of work going on to look
at whether there is a signal in relation to what we call venous
thrombo-embolic events - clots," Jonathan Van-Tam said at a news
conference on Wednesday.
"And there's a lot of evidence emerging now that is
reassuring that there is no overall excess signal or increased
risk. And I expect, without prejudice to their absolute
findings, those to be the final conclusions of the EMA and
(Britain's) MHRA in due course."
(Reporting by Michael Holden, writing by Alistair Smout)